Clin2
NCT06835582Possibly a fitEnrolling by invitation

Checking Methadone and Its Breakdown Levels

Opioid Use DisorderPain

Treatments studied

Part of Mental health, Pain clinical trials.

This study is checking the levels of methadone and its breakdown products in your blood. It helps make sure the medication is working safely for conditions like opioid use disorder or chronic pain.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old.
  • You take methadone (10 mg or more daily) for at least 7 days, for opioid use disorder or pain.
  • You have at least one day's worth of take-home doses of methadone.
  • Your methadone dose has been stable for the last 4 days before joining the study.
  • You do not have a condition that makes blood draws unsafe, like a bleeding disorder, certain skin conditions, anemia, or active severe depression.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05459402Recruiting· Phase 2/Phase 3
Methadone dose testing for opioid use disorder pain relief

This study compares taking methadone as one dose versus split into two doses to see which approach works better for people who have pain. It’s meant for adults already on a steady methadone program and who can follow study visits and procedures.

Baltimore, Maryland
NCT06323824Recruiting· Phase 4
Methadone vs. buprenorphine for opioid use disorder treatment

This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.

Oakland, California
NCT06207162Recruiting
Brain scans and methadone treatment for opioid recovery

This study uses MRI scans over time to track brain changes in people with opioid use disorder who recently started methadone treatment. You can help researchers understand recovery patterns if you are early in your methadone journey and can commit to repeated visits.

New Haven, Connecticut
NCT07546396Not yet recruiting· Phase 4
Rapid Methadone Restart After Short Break

This study helps people with opioid addiction quickly restart methadone treatment after stopping for a few days. Researchers want to see if restarting methadone safely can reduce fentanyl use and prevent overdose.

Vancouver, British Columbia
NCT05027919Recruiting· Phase 2
Testing ways to predict opioid withdrawal during a taper

This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.

Baltimore, Maryland
NCT06338280Recruiting· Phase 2
Observing methadone treatment remotely

This study tests if using a smartphone app to watch you take your methadone works as well as going to a clinic every day. It might make treatment easier for you.

Chicago, Illinois

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.